FUM vs. SCLP, MPH, ORPH, OBI, REDX, ETX, SBTX, COS, C4XD, and DDDD
Should you be buying Futura Medical stock or one of its competitors? The main competitors of Futura Medical include Scancell (SCLP), Mereo BioPharma Group plc (MPH.L) (MPH), Open Orphan (ORPH), Ondine Biomedical (OBI), Redx Pharma (REDX), e-therapeutics (ETX), SkinBioTherapeutics (SBTX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), and 4D pharma (DDDD). These companies are all part of the "biotechnology" industry.
Futura Medical vs.
Scancell (LON:SCLP) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.
Scancell has a net margin of 0.00% compared to Futura Medical's net margin of -44.64%. Scancell's return on equity of 98.74% beat Futura Medical's return on equity.
46.5% of Scancell shares are held by institutional investors. Comparatively, 35.7% of Futura Medical shares are held by institutional investors. 5.0% of Scancell shares are held by insiders. Comparatively, 32.1% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Scancell has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500.
Scancell received 1 more outperform votes than Futura Medical when rated by MarketBeat users. Likewise, 74.50% of users gave Scancell an outperform vote while only 64.36% of users gave Futura Medical an outperform vote.
Futura Medical has higher revenue and earnings than Scancell. Scancell is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Scancell had 4 more articles in the media than Futura Medical. MarketBeat recorded 4 mentions for Scancell and 0 mentions for Futura Medical. Scancell's average media sentiment score of 0.90 beat Futura Medical's score of 0.00 indicating that Scancell is being referred to more favorably in the media.
Summary
Scancell beats Futura Medical on 8 of the 14 factors compared between the two stocks.
Get Futura Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Futura Medical Competitors List
Related Companies and Tools
This page (LON:FUM) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy FUM Stock Free FUM Stock Alerts